Skip to content

Opening book details…

About this Medicine article

A Phase I Dose Escalation and Expansion Trial of BKM120, An Oral Pan-PI3K Inhibitor, in Patients with Advanced Solid Tumors: Analysis of Pharmacodynamic Biomarker Data by Rodon, J.; Bendell, J.; Razak, A.R.A.; De Jonge, M.J.A.; Eskens, F.; Di Tomaso, E.; Sternberg, D.W.; Wang, L.; Sarr, C.; Baselga, J. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Rodon, J.; Bendell, J.; Razak, A.R.A.; De Jonge, M.J.A.; Eskens, F.; Di Tomaso, E.; Sternberg, D.W.; Wang, L.; Sarr, C.; Baselga, J.
Publisher
Oxford University Press; Elsevier BV (ISSN 0923-7534)
Published
2012
Field
Medicine (Health Sciences)

More by Rodon, J.; Bendell, J.; Razak, A.R.A.; De Jonge, M.J.A.; Eskens, F.; Di Tomaso, E.; Sternberg, D.W.; Wang, L.; Sarr, C.; Baselga, J.

Browse all works by Rodon, J.; Bendell, J.; Razak, A.R.A.; De Jonge, M.J.A.; Eskens, F.; Di Tomaso, E.; Sternberg, D.W.; Wang, L.; Sarr, C.; Baselga, J.